These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22913272)

  • 1. Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in tumorigenesis and metastasis.
    Luo X; Chen L; Dai J; Gao Y; Wang H; Wang N; Zhao Y; Liu F; Sang Z; Wang J; Li W; He K; Jin B; Man J; Zhang W; Xia Q
    BMC Med Genomics; 2012 Aug; 5():36. PubMed ID: 22913272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
    Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
    Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.
    Sakurai T; Yada N; Hagiwara S; Arizumi T; Minaga K; Kamata K; Takenaka M; Minami Y; Watanabe T; Nishida N; Kudo M
    Cancer Sci; 2017 Oct; 108(10):1996-2003. PubMed ID: 28777492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of human oncoprotein gankyrin in Zebrafish.
    Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
    Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
    Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
    Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin.
    Xu X; Lou Y; Tang J; Teng Y; Zhang Z; Yin Y; Zhuo H; Tan Z
    Cell Death Dis; 2019 Jan; 10(2):86. PubMed ID: 30692513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines.
    Taheri T; Jamialahmadi K; Khadijeh F
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3413-3418. PubMed ID: 29286612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells.
    Gao L; Xie H; Dong L; Zou J; Fu J; Gao X; Ou L; Xiang S; Song H
    Mol Med Rep; 2014 Mar; 9(3):1032-6. PubMed ID: 24337075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma.
    Hwang JA; Yang HM; Hong DP; Joo SY; Choi YL; Park JH; Lazar AJ; Pollock RE; Lev D; Kim SJ
    Oncotarget; 2014 Oct; 5(19):9065-78. PubMed ID: 25238053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Microcystin-LR Exposure Induces Hepatocarcinogenesis via Increased Gankyrin in Vitro and in Vivo.
    He L; Huang Y; Guo Q; Zeng H; Zheng C; Wang J; Chen JA; Wang L; Shu W
    Cell Physiol Biochem; 2018; 49(4):1420-1430. PubMed ID: 30205410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression.
    Kim YH; Kim JH; Choi YW; Lim SK; Yim H; Kang SY; Chung YS; Lee GY; Park TJ
    Exp Mol Pathol; 2013 Apr; 94(2):360-5. PubMed ID: 23276718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
    Cheng L; Wu B; Zhang L; Bian E; An R; Yu S; Liu W; Xiong Z
    Cell Signal; 2020 Jan; 65():109460. PubMed ID: 31678253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
    Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
    Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
    Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
    Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gankyrin: a new oncoprotein and regulator of pRb and p53.
    Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ
    Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
    Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
    World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
    Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
    Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
    Higashitsuji H; Liu Y; Mayer RJ; Fujita J
    Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.